These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32533350)

  • 21. Bacteriophages and bacterial extracellular vesicles, threat or opportunity?
    Meidaninikjeh S; Mohammadi P; Elikaei A
    Life Sci; 2024 Aug; 350():122749. PubMed ID: 38821215
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phage Therapy Faces Evolutionary Challenges.
    Torres-Barceló C
    Viruses; 2018 Jun; 10(6):. PubMed ID: 29895791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phage Therapy in Bacterial Infections Treatment: One Hundred Years After the Discovery of Bacteriophages.
    Cisek AA; Dąbrowska I; Gregorczyk KP; Wyżewski Z
    Curr Microbiol; 2017 Feb; 74(2):277-283. PubMed ID: 27896482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phage therapy: breathing new tactics into lower respiratory tract infection treatments.
    Vaezi A; Healy T; Ebrahimi G; Rezvankhah S; Hashemi Shahraki A; Mirsaeidi M
    Eur Respir Rev; 2024 Apr; 33(172):. PubMed ID: 38925791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phage Therapy Approaches to Reducing Pathogen Persistence and Transmission in Animal Production Environments: Opportunities and Challenges.
    Colavecchio A; Goodridge LD
    Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28664828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expert Opinion on Three Phage Therapy Related Topics: Bacterial Phage Resistance, Phage Training and Prophages in Bacterial Production Strains.
    Rohde C; Resch G; Pirnay JP; Blasdel BG; Debarbieux L; Gelman D; Górski A; Hazan R; Huys I; Kakabadze E; Łobocka M; Maestri A; Almeida GMF; Makalatia K; Malik DJ; Mašlaňová I; Merabishvili M; Pantucek R; Rose T; Štveráková D; Van Raemdonck H; Verbeken G; Chanishvili N
    Viruses; 2018 Apr; 10(4):. PubMed ID: 29621199
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phage Therapy for Antibiotic-Resistant Bacterial Infections.
    Hatfull GF; Dedrick RM; Schooley RT
    Annu Rev Med; 2022 Jan; 73():197-211. PubMed ID: 34428079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reapproaching Old Treatments: Considerations for PK/PD Studies on Phage Therapy for Bacterial Respiratory Infections.
    Schmalstig AA; Freidy S; Hanafin PO; Braunstein M; Rao GG
    Clin Pharmacol Ther; 2021 Jun; 109(6):1443-1456. PubMed ID: 33615463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outside-host phage therapy as a biological control against environmental infectious diseases.
    Merikanto I; Laakso JT; Kaitala V
    Theor Biol Med Model; 2018 Jun; 15(1):7. PubMed ID: 29879998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Propagation, Purification, and Characterization of Bacteriophages for Phage Therapy.
    Kosznik-Kwaśnicka K; Topka G; Mantej J; Grabowski Ł; Necel A; Węgrzyn G; Węgrzyn A
    Methods Mol Biol; 2024; 2738():357-400. PubMed ID: 37966610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phage Therapy: The Pharmacology of Antibacterial Viruses.
    Danis-Wlodarczyk K; Dąbrowska K; Abedon ST
    Curr Issues Mol Biol; 2021; 40():81-164. PubMed ID: 32503951
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phage Therapy: Going Temperate?
    Monteiro R; Pires DP; Costa AR; Azeredo J
    Trends Microbiol; 2019 Apr; 27(4):368-378. PubMed ID: 30466900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bacteriophages: the possible solution to treat infections caused by pathogenic bacteria.
    El-Shibiny A; El-Sahhar S
    Can J Microbiol; 2017 Nov; 63(11):865-879. PubMed ID: 28863269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Phage therapy, an alternative to antibiotic therapy?)].
    Reina J; Reina N
    Rev Esp Quimioter; 2018 Apr; 31(2):101-104. PubMed ID: 29451376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bacteriophage therapy as an alternative treatment for human infections. A comprehensive review.
    Kakasis A; Panitsa G
    Int J Antimicrob Agents; 2019 Jan; 53(1):16-21. PubMed ID: 30236954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. More than Simple Parasites: the Sociobiology of Bacteriophages and Their Bacterial Hosts.
    Secor PR; Dandekar AA
    mBio; 2020 Mar; 11(2):. PubMed ID: 32156804
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biological challenges of phage therapy and proposed solutions: a literature review.
    Caflisch KM; Suh GA; Patel R
    Expert Rev Anti Infect Ther; 2019 Dec; 17(12):1011-1041. PubMed ID: 31735090
    [No Abstract]   [Full Text] [Related]  

  • 38. Computational models of populations of bacteria and lytic phage.
    Krysiak-Baltyn K; Martin GJ; Stickland AD; Scales PJ; Gras SL
    Crit Rev Microbiol; 2016 Nov; 42(6):942-68. PubMed ID: 26828960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steering Phages to Combat Bacterial Pathogens.
    Gurney J; Brown SP; Kaltz O; Hochberg ME
    Trends Microbiol; 2020 Feb; 28(2):85-94. PubMed ID: 31744662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination of in vivo phage therapy data with in silico model highlights key parameters for pneumonia treatment efficacy.
    Delattre R; Seurat J; Haddad F; Nguyen TT; Gaborieau B; Kane R; Dufour N; Ricard JD; Guedj J; Debarbieux L
    Cell Rep; 2022 May; 39(7):110825. PubMed ID: 35584666
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.